Copy
See below for a daily digest of the latest Huntington's Disease news!

Neuroprotective Pathway May Be Key to Understanding Huntington’s Progression

May 25, 2017 06:14 pm | Magdalena Kegel

 

Neuroprotective Pathway neural stem cellsA team of researchers has discovered new insights into cell processes that have gone awry in Huntingon’s disease (HD) patients. This discovery could point scientists toward a potential method of interfering with those processes. The study, “KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington’s disease patients,” was published in the journal Proceedings […]

The post Neuroprotective Pathway May Be Key to Understanding Huntington’s Progression appeared first on Huntington's Disease News.

Read More
share on Twitter Like Neuroprotective Pathway May Be Key to Understanding Huntington’s Progression on Facebook

University of Sussex Researchers Receive $3.37 Million to Develop Huntington’s Treatments

May 23, 2017 09:47 am | Alice Melao

 

Huntington's research grantResearchers at the Sussex Drug Discovery Centre in Brighton, England, have received a £3 million grant from Britain’s non-profit Wellcome Trust to develop Huntington’s disease treatments. The team will team up with other researchers to target a protein that plays a role in cognitive impairment, one of the hallmarks of the neurological disease. The grant is equivalent to $3.37 […]

The post University of Sussex Researchers Receive $3.37 Million to Develop Huntington’s Treatments appeared first on Huntington's Disease News.

Read More
share on Twitter Like University of Sussex Researchers Receive $3.37 Million to Develop Huntington’s Treatments on Facebook

Researchers Discover Why Defects Form in Blood Brain Barrier of Huntington’s Patients

May 18, 2017 12:20 pm | Alice Melao

 

defects in blood brain barrierResearchers have discovered why Huntington’s disease (HD) patients have defects in the blood-brain barrier that contribute to the symptoms of this neurological disorder. Their study, “Huntington’s Disease iPSC-Derived Brain Microvascular Endothelial Cells Reveal WNT-Mediated Angiogenic and Blood-Brain Barrier Deficits,” was published in Cell Reports. “Now we know there are internal problems with blood vessels in the […]

The post Researchers Discover Why Defects Form in Blood Brain Barrier of Huntington’s Patients appeared first on Huntington's Disease News.

Read More
share on Twitter Like Researchers Discover Why Defects Form in Blood Brain Barrier of Huntington’s Patients on Facebook

WAVE Life Sciences Continues Development of Two Drug Therapies for Huntington’s

May 16, 2017 12:46 pm | Joana Fernandes, PhD

 

WAVE Life SciencesWAVE Life Sciences’ products WVE-120101 (SNP-1) and WVE-120102 (SNP-2) will enter clinical trials in mid-2017 as part of the effort to develop new treatments for patients with Huntington’s disease. “2017 will be an important year for WAVE as we transition our two lead candidates in Huntington’s disease … into clinical trials,” Paul Bolno, MD, and […]

The post WAVE Life Sciences Continues Development of Two Drug Therapies for Huntington’s appeared first on Huntington's Disease News.

Read More
share on Twitter Like WAVE Life Sciences Continues Development of Two Drug Therapies for Huntington’s on Facebook

Recent Posts

Taube Philanthropies Donates $3 Million to Stanford, Gladstone for Huntington’s Research
Huntington’s May Be Caused by Disrupted Transport of Molecules Within Neurons
Phase 1/2 Trial of SBT-20 In Early-stage Huntington’s Begins in Holland
Treatment with VX15 May Protect Brain in Early Phase Huntington’s, Data Shows
Clinical Trial Results Suggest Teva’s Pridopidine May Delay Functional Decline in Huntington’s Patients

Copyright © 2017 BioNews Inc., All rights reserved.
Email Marketing Powered by Mailchimp
unsubscribe from this list | update subscription preferences